101 related articles for article (PubMed ID: 10516227)
1. Soluble guanylate cyclase gene expression and localization in rat lung after exposure to hypoxia.
Li D; Zhou N; Johns RA
Am J Physiol; 1999 Oct; 277(4):L841-7. PubMed ID: 10516227
[TBL] [Abstract][Full Text] [Related]
2. Impaired iNOS-sGC-cGMP signalling contributes to chronic hypoxic and hypercapnic pulmonary hypertension in rat.
Xia XD; Xu ZJ; Hu XG; Wu CY; Dai YR; Yang L
Cell Biochem Funct; 2012 Jun; 30(4):279-85. PubMed ID: 22290599
[TBL] [Abstract][Full Text] [Related]
3. [Study on soluble guanylate cyclase in pulmonary hypertension rat model].
Xia XD; Xu ZJ; Bi YT; Dai YR; Wu SZ
Zhonghua Nei Ke Za Zhi; 2003 Sep; 42(9):628-31. PubMed ID: 14514391
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia decreases expression of soluble guanylate cyclase in cultured rat pulmonary artery smooth muscle cells.
Hassoun PM; Filippov G; Fogel M; Donaldson C; Kayyali US; Shimoda LA; Bloch KD
Am J Respir Cell Mol Biol; 2004 Jun; 30(6):908-13. PubMed ID: 14754757
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of lung soluble guanylate cyclase during chronic hypoxia is prevented by deletion of eNOS.
Li D; Laubach VE; Johns RA
Am J Physiol Lung Cell Mol Physiol; 2001 Aug; 281(2):L369-76. PubMed ID: 11435211
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary soluble guanylate cyclase, a nitric oxide receptor, is increased during the perinatal period.
Bloch KD; Filippov G; Sanchez LS; Nakane M; de la Monte SM
Am J Physiol; 1997 Mar; 272(3 Pt 1):L400-6. PubMed ID: 9124595
[TBL] [Abstract][Full Text] [Related]
7. Regulation of soluble guanylyl cyclase-alpha1 expression in chronic hypoxia-induced pulmonary hypertension: role of NFATc3 and HuR.
de Frutos S; Nitta CH; Caldwell E; Friedman J; González Bosc LV
Am J Physiol Lung Cell Mol Physiol; 2009 Sep; 297(3):L475-86. PubMed ID: 19592461
[TBL] [Abstract][Full Text] [Related]
8. Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension.
Schermuly RT; Stasch JP; Pullamsetti SS; Middendorff R; Müller D; Schlüter KD; Dingendorf A; Hackemack S; Kolosionek E; Kaulen C; Dumitrascu R; Weissmann N; Mittendorf J; Klepetko W; Seeger W; Ghofrani HA; Grimminger F
Eur Respir J; 2008 Oct; 32(4):881-91. PubMed ID: 18550612
[TBL] [Abstract][Full Text] [Related]
9. Soluble guanylate cyclase-alpha1 deficiency selectively inhibits the pulmonary vasodilator response to nitric oxide and increases the pulmonary vascular remodeling response to chronic hypoxia.
Vermeersch P; Buys E; Pokreisz P; Marsboom G; Ichinose F; Sips P; Pellens M; Gillijns H; Swinnen M; Graveline A; Collen D; Dewerchin M; Brouckaert P; Bloch KD; Janssens S
Circulation; 2007 Aug; 116(8):936-43. PubMed ID: 17679618
[TBL] [Abstract][Full Text] [Related]
10. Dehydroepiandrosterone upregulates soluble guanylate cyclase and inhibits hypoxic pulmonary hypertension.
Oka M; Karoor V; Homma N; Nagaoka T; Sakao E; Golembeski SM; Limbird J; Imamura M; Gebb SA; Fagan KA; McMurtry IF
Cardiovasc Res; 2007 Jun; 74(3):377-87. PubMed ID: 17346686
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide decreases stability of mRNAs encoding soluble guanylate cyclase subunits in rat pulmonary artery smooth muscle cells.
Filippov G; Bloch DB; Bloch KD
J Clin Invest; 1997 Aug; 100(4):942-8. PubMed ID: 9259594
[TBL] [Abstract][Full Text] [Related]
12. Activation of soluble guanylate cyclase reverses experimental pulmonary hypertension and vascular remodeling.
Dumitrascu R; Weissmann N; Ghofrani HA; Dony E; Beuerlein K; Schmidt H; Stasch JP; Gnoth MJ; Seeger W; Grimminger F; Schermuly RT
Circulation; 2006 Jan; 113(2):286-95. PubMed ID: 16391154
[TBL] [Abstract][Full Text] [Related]
13. Escherichia coli lipopolysaccharide downregulates soluble guanylate cyclase in pulmonary artery smooth muscle.
Scott WS; Nakayama DK
J Surg Res; 1998 Dec; 80(2):309-14. PubMed ID: 9878330
[TBL] [Abstract][Full Text] [Related]
14. Distribution of NOS in normoxic vs. hypoxic rat lung: upregulation of NOS by chronic hypoxia.
Xue C; Rengasamy A; Le Cras TD; Koberna PA; Dailey GC; Johns RA
Am J Physiol; 1994 Dec; 267(6 Pt 1):L667-78. PubMed ID: 7528981
[TBL] [Abstract][Full Text] [Related]
15. Sustained nitric oxide exposure decreases soluble guanylate cyclase mRNA and enzyme activity in pulmonary artery smooth muscle.
Scott WS; Nakayama DK
J Surg Res; 1998 Sep; 79(1):66-70. PubMed ID: 9735242
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of nitric oxide synthase correlates temporally with onset of pulmonary vascular remodeling in the hypoxic rat.
Xue C; Johns RA
Hypertension; 1996 Nov; 28(5):743-53. PubMed ID: 8901818
[TBL] [Abstract][Full Text] [Related]
17. Role of pentose phosphate pathway-derived NADPH in hypoxic pulmonary vasoconstriction.
Gupte SA; Okada T; McMurtry IF; Oka M
Pulm Pharmacol Ther; 2006; 19(4):303-9. PubMed ID: 16203165
[TBL] [Abstract][Full Text] [Related]
18. Atrial natriuretic peptide accounts for increased cGMP in hypoxia-induced hypertensive rat lungs.
Muramatsu M; Tyler RC; Gutkowska J; Klinger JR; Hill NS; Rodman DM; McMurtry IF
Am J Physiol; 1997 Jun; 272(6 Pt 1):L1126-32. PubMed ID: 9227514
[TBL] [Abstract][Full Text] [Related]
19. Effects of chronic hypoxia and altered hemodynamics on endothelial nitric oxide synthase expression in the adult rat lung.
Le Cras TD; Tyler RC; Horan MP; Morris KG; Tuder RM; McMurtry IF; Johns RA; Abman SH
J Clin Invest; 1998 Feb; 101(4):795-801. PubMed ID: 9466974
[TBL] [Abstract][Full Text] [Related]
20. [Effect of hypoxia on distribution and activity of nitric oxide synthase in rat lung].
Lin H; Cai Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Apr; 19(2):110-5. PubMed ID: 10453504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
